Social Media Ideas for Oig Advisory Opinion 26-11

HHS-OIG Issues Favorable Advisory Opinion Regarding Independent Charity Patient Assistance Program

HHS-OIG Issues Favorable Advisory Opinion Regarding Healthcare Referral Service

When Free Is Permissible: OIG Allows Free Supplemental Cancer Screening Reports for Eligible Patients

On May 20, 2026, the Department of Health and Human Services Office of Inspector General (“OIG”) posted a favorable opinion, AO 26-11, regarding an arrangement in which a precision...

When Hearing Referrals Are Sound: OIG Issues Favorable Opinion on Ear and Hearing Referral Services

On September 9, 2026, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) published Advisory Opinion 26-18 (“AO 26-18”), a favorable advisory opini...

CMS Receives Its Exclusion Authority: What Happens Now?

VA OIG Releases Report on the Federal Supply Schedule Program

DOJ’s Fraud Division and HHS-OIG Streamline Self-Disclosure of Criminal Healthcare Fraud

DOJ Revises Justice Manual on Non-Binding Guidance and Qui Tam Dismissals: Practical Considerations

A More Unified Path to Self-Disclosure: DOJ and HHS-OIG Harmonize Health Care Fraud Policies

Tax Administration, Sham Partnerships, and Voluntary Compliance: Understanding the Eleventh Circuit’s Affirmation of the...

Filipowski v. Commissioner, No. 25-11382 (11th Cir. 2025), September 2, 2026 For tax professionals representing clients with significant tax delinquencies, the Offer-in-Comp...

OIG Clarifies That Stark Law Compliance and Fair Market Value Alone Do Not Resolve Anti-Kickback Statute Risk

In revisions released earlier this year to its General Questions Regarding Certain Fraud and Abuse Authorities, the Office of Inspector General (“OIG”) emphasized that compliance w...

Federal Court Upholds CMS’s OPO Performance Rule but Allows Earlier Judicial Challenges

On September 29, 2026, in LifeLink Foundation, Inc. v. Kennedy, the U.S. District Court for the Middle District of Florida (the “Court”) upheld the Centers for Medicare & Medic...

DOJ, HHS Announce One-Stop Shop for Companies Voluntarily Disclosing Potential Health Care Fraud

Déjà Vu as DOJ Resumes Sub-regulatory Guidance Limits and FCA Dismissal Policy

DOJ Rejects Petition to Allow Labs to Compensate Employed Sales Reps Using Variable Compensation Under EKRA

CMS Gains Permissive Exclusion Authority: Implications for Pharma and Medical Device Companies

By Anne K. Walsh —

Cooperation, Compliance, and Consequences: Inside DOJ's $46 Million Veloxis Settlement

Regulatory Scrutiny in ABA: What Providers Need to Know About Compliance Oversight

What DOJ’s Expanded Wound-Care-Fraud Enforcement Might Mean for Providers and Suppliers Heading Into Year-End 2026

Four Is A Trend: Lessons For Medicare Advantage Diagnosis Coding Programs To Take From Recent FCA Settlements

DOJ Corporate Fraud Enforcement Memo: What Health Care Companies Need to Know Now

Section 4958 Excise Tax Exposure and Automatic Excess Benefits: Analyzing Jagannath v. Commissioner

Jagannath v. Commissioner, T.C. Memo. 2026-92 (Sept. 24, 2026) In Jagannath v. Commissioner, T.C. Memo. 2026-92 (Filed September 24, 2026), the United States Tax Court address...

RFI Seeks Input on Medicare Part D’s Pharmacy Contract Standards

340B Rebate Pilot — The Clock Starts Now